Myasthenia Gravis
USMLE Step 1 trap: Confuses the fatigability pattern of MG (worsens with use) with Lambert-Eaton (transiently improves with use). Lambert-Eaton syndrome improves transiently with repeated use (post-tetanic potentiation) because repetitive stimulation increases ACh release, while MG worsens with use.
Myasthenia gravis (MG) is an autoimmune disease where antibodies destroy postsynaptic nicotinic acetylcholine receptors at the neuromuscular junction, causing fatigable muscle weakness — and USMLE Step 1 tests it from multiple angles. Students routinely confuse the pre- vs. postsynaptic antibody targets (MG = postsynaptic AChR; Lambert-Eaton = presynaptic VGCC), and misapply the fatigability pattern: Lambert-Eaton transiently improves with repeated use, not worsens. The other high-yield trap is crisis management — students reach for more pyridostigmine, which is exactly wrong. The key word for MG is fatigable: strength decreases with sustained activity and recovers with rest, and ptosis worse in the evening is the classic opening presentation.
The exam specifically likes to pit MG against Lambert-Eaton myasthenic syndrome (LEMS) — they share superficial similarities (NMJ disease, weakness) but differ in antibody target, weakness pattern, and associated cancers. MG is also commonly tested alongside thymoma: roughly 10-15% of MG patients have a thymoma, and CT chest is part of the workup. USMLE Step 1 will also drop you into a scenario where someone's MG is decompensating and ask how to manage it — knowing when NOT to give more pyridostigmine is critical.
What trips students up most: confusing the pre- vs. postsynaptic antibody targets (MG = postsynaptic AChR; LEMS = presynaptic VGCC), and misapplying the fatigability pattern. Lambert-Eaton actually transiently improves with repeated use, not worsens — the opposite of MG. Students also tend to reach for more pyridostigmine in a crisis, which is exactly wrong. Nail these distinctions and this topic becomes very manageable.
Common misconceptions
What the exam tests
- Mechanism: Identify the specific antibody target in MG (postsynaptic nicotinic AChR, or MuSK) and understand how antibody-mediated receptor destruction at the NMJ causes fatigable weakness.
- Presentation: Recognize the classic MG pattern — ptosis and diplopia that worsen throughout the day, proximal limb weakness, bulbar symptoms — and know the demographic associations (young women and older men).
- Diagnosis: Know which antibody tests to order (anti-AChR first, then anti-MuSK if negative), how the edrophonium (Tensilon) test works, what repetitive nerve stimulation shows on EMG (decremental response), and why CT chest is needed to rule out thymoma.
- Crisis management: Know the distinction between myasthenic crisis (NMJ failure, respiratory compromise) and cholinergic crisis, and understand why anticholinesterases are typically held during myasthenic crisis while plasmapheresis or IVIG plus ventilatory support are used.
- Lambert-Eaton contrast: Distinguish MG from Lambert-Eaton syndrome by antibody target (VGCC vs. AChR), weakness pattern (improves transiently with repetition vs. worsens), associated cancer (small cell lung vs. thymoma), and EMG findings (incremental vs. decremental response).
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →